Algérie < Allemagne < Arabie saoudite

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 356.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000027 (2006)	H U Scherer [Allemagne] ; G-R Burmester	[Biologicals in the treatment of rheumatic diseases].
000039 (2007)	M. Schneider [Allemagne]	Exploring new territory: considering the future.
000084 (2008)	P. Emery [Royaume-Uni] ; E. Keystone [Canada] ; H P Tony [Allemagne] ; A. Cantagrel [France] ; R. Van Vollenhoven [Suède] ; A. Sanchez [Mexique] ; E. Alecock [Royaume-Uni] ; J. Lee [États-Unis] ; J. Kremer [États-Unis]	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
000120 (2008)	Susanne Heinzl [Allemagne]	[Tocilizumab in rheumatoid arthritis. Interleukin 6 as a new target].
000130 (2009)	Eugen Feist [Allemagne] ; Gerd-R Burmester	Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?
000143 (2009)	Kay Stubenrauch [Allemagne] ; Uwe Wessels ; Rudolf Vogel ; Julia Schleypen	Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards.
000167 (2009)	Hans Ulrich Scherer [Allemagne] ; Gerd R. Burmester	A clinical perspective of rheumatoid arthritis.
000174 (2010)	Claudia Drucker [Allemagne] ; Jessica Gewiese ; Sven Malchow ; Jürgen Scheller ; Stefan Rose-John	Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.
000175 (2009)	H-M Lorenz [Allemagne]	[Do biologicals have a place in the treatment of collagen diseases? Pro].
000185 (????)	J. Braun [Allemagne] ; J R Kalden	Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis.
000220 (2010)	Josef S. Smolen [Autriche] ; Daniel Aletaha [Autriche] ; Johannes W J. Bijlsma [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Dimitrios Boumpas [Grèce] ; Gerd Burmester [Allemagne] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Maarten De Wit [Suisse] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Alan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Boulos Haraoui [Canada] ; Joachim Kalden [Allemagne] ; Edward C. Keystone [Canada] ; Tore K. Kvien [Norvège] ; Iain Mcinnes [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Monika Schoels [Autriche] ; Desirée Van Der Heijde [Pays-Bas]	Treating rheumatoid arthritis to target: recommendations of an international task force
000239 (2010)	Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Cecile Gaujoux-Viala [France] ; Simone Gorter [Pays-Bas] ; Rachel Knevel [Pays-Bas] ; Jackie Nam [Royaume-Uni] ; Monika Schoels [Autriche] ; Daniel Aletaha [Autriche] ; Maya Buch [Royaume-Uni] ; Laure Gossec [France] ; Tom Huizinga [Pays-Bas] ; Johannes W J W. Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Marios Kouloumas [Suisse] ; Tore K. Kvien [Norvège] ; Emilio Martin-Mola [Espagne] ; Iain Mcinnes [Royaume-Uni] ; Karel Pavelka [République tchèque] ; Piet Van Riel [Pays-Bas] ; Marieke Scholte [Suisse] ; David L. Scott [Royaume-Uni] ; Tuulikki Sokka [Finlande] ; Guido Valesini [Italie] ; Ronald Van Vollenhoven [Suède] ; Kevin L. Winthrop [États-Unis] ; John Wong [États-Unis] ; Angela Zink [Allemagne] ; Désirée Van Der Heijde [Pays-Bas]	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
000246 (2010)	A. Gause [Allemagne] ; A. Rubbert-Roth ; H. Michels ; M. Gaubitz ; W-J Mayet	[Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis].
000272 (2010)	J. Wollenhaupt [Allemagne] ; K. Krüger	[Non-TNF biologicals in the therapeutic strategy for rheumatoid arthritis].
000273 (2010)	P. Roll [Allemagne] ; A. Rubbert-Roth ; H-P Tony	[Tocilizumab. What comes after TNF-blockers in clinical routine?].
000277 (2010)	Matthias Geyer [Allemagne] ; Ulf Müller-Ladner [Allemagne]	Rationale of using different biological therapies in rheumatoid arthritis
000280 (2010)	G. Horneff [Allemagne]	[Juvenile arthritides].
000296 (2009)	Ulf Müller-Ladner [Allemagne] ; Elena Neumann ; Ingo H. Tarner	Clinically relevant advances in rheumatoid arthritis therapy.
000305 (2010)	Kay Stubenrauch [Allemagne] ; Uwe Wessels ; Herbert Birnboeck ; Francisco Ramirez ; Angelika Jahreis ; Julia Schleypen	Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing.
000311 (????)	R. Rau [Allemagne]	Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis.
000324 (2010)	Olaf Schultz [Allemagne] ; Frank Oberhauser ; Jasemine Saech ; Andrea Rubbert-Roth ; Moritz Hahn ; Wilhelm Krone ; Matthias Laudes	Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i -k "Allemagne" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i  \
                -Sk "Allemagne" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Allemagne
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021